Article information
Full text is only aviable in PDF
Bibliografía
[1.]
M.C. Fiore, W.C. Bailey, S.J. Cohen, S.F. Dorfman, M.G. Goldstein, E.R. Gritz, et al.
Treating tobacco use and dependence. Clinical Practice guideline,
[2.]
M.C. Fiore, D.E. Joremby, A.E. Schensky, S.S. Smith, R.R. Bauer, T.B. Baker.
Smoking status as the new vital sign: effect on assessment and intervention in the patients who smoke.
Mayo Clin Proc, 70 (1995), pp. 209-213
[3.]
J.R. Banegas Banegas, L. Díez Gañan, F. Rodríguez-Artalejo, J. González Enríquez, A. Graciani, F. Villar.
Mortalidad atribuible al tabaquismo en España en 1998.
Med Clin (Barc), 117 (2001), pp. 692-694
[4.]
World Health Organization.
The European report on tobacco control policy. WHO European ministerial conference for a tobaccofree Europe,
[5.]
R. Peto.
Smoking and death: the past 40 years and the next 40.
Bmj, 309 (1994), pp. 937-939
[6.]
C.A. Jiménez Ruiz, S. Solano Reina, J.M. González de Vega, M. Ruiz Pardo, S. Flórez Martín, A. Ramos Pinedo, et al.
Normativa para el tratamiento del tabaquismo.
Arch Bronconeumol, 335 (1999), pp. 499-506
[7.]
C.A. Jiménez Ruiz, S. Solano Reina, M. Barrueco Ferrero, J.I. de Granda Orive, J.J. Lorza Blasco, S. Alonso Viteri, et al.
Recomendaciones para la organización y funcionamiento de las unidades especializadas en tabaquismo.
Arch Bronconeumol, 37 (2001), pp. 382-387
[8.]
C.A. Jiménez Ruiz, M. Barrueco Ferrero, S. Solano Reina, M. Torrecilla García, F. Domínguez Grandal, J.L. Díaz-Maroto Muñoz, et al.
Recomendaciones en el abordaje diagnóstico y terapéutico del tabaquismo. Documento de consenso.
Arch Bronconeumol, 39 (2003), pp. 35-41
[9.]
C.A. Jiménez Ruiz, J. Ayesta, M.A. Planchuelo, R. Abéngozar, M. Torrecilla, A.M. Quintas, et al.
Recomendaciones de la Sociedad Española de Especialistas en Tabaquismo para el tratamiento farmacológico del tabaquismo.
Prev Tab, 3 (2001), pp. 78-85
[10.]
Ayudar a dejar de fumar.
Protocolos de actuación para profesionales de salud. Programa de ayuda al fumador. Instituto de Salud Pública.
Gobierno de Navarra. Departamento de Salud,
[11.]
The smoking cessation clinical practice guideline.
Panel and staff. The Agency for Health Care Policy and Research.
Jama, 275 (1996), pp. 1270-1280
[12.]
R. West, A. McNeill, M. Raw.
Smoking cessation guidelines for health professionals: an update.
Thorax, 55 (2000), pp. 987-999
[13.]
Akehurst RL, Bernett D, Berry C, Bird S, Buxton M, Claxton K, et al. Guidance on the use of nicotine replacement therapy and bupropion for smoking cessation. National Institute for Clinical Excellence. Disponible en: www.nice.org.uk
[14.]
World Health Organization.
European Partnership project. First European guideline in the treatment of tobacco dependence,
[15.]
J.E. Andersson, D.E. Joremby, W.J. Scott, M.C. Fiore.
Treating tobacco use and dependence.
Chest, 121 (2002), pp. 932-941
[16.]
C. Silagy, L.F. Stead.
Physician advice for smoking cessation. Cochrane Library. N 2,
[17.]
C. Silagy.
Physician advice for smoking cessation. Cochrane Library. N 2,
[18.]
V.H. Rice, L.F. Stead.
Nursing interventions for smoking cessation. Cochrane Library. N 3,
[19.]
V.H. Rice, L.F. Stead.
Nursing interventions for smoking cessation. Cochrane Library. N 2,
[20.]
P. Hajek, T.Z. Taylor, P. Mills.
Brief intervention during hospital admission to help patients to give up smoking after myocardial infarction and bypass surgery: randomised controlled trial.
Bmj, 324 (2002), pp. 87-89
[21.]
L.F. Stead, T. Lancaster.
Group behaviour therapy programmes for smoking cessation. Cochrane Library. N 2,
[22.]
T. Lancaster, L.F. Stead.
Individual behavioural counselling for smoking cessation. Cochrane Library. N 2,
[23.]
T. Lancaster, L.F. Stead.
Individual behavioural counselling for smoking cessation. Cochrane Library. N 1,
[24.]
L.F. Stead, T. Lancaster.
Group behaviour therapy programmes for smoking cessation. Cochrane library. N 1,
[25.]
L.F. Stead, T. Lancaster.
Telephone counselling for smoking cessation. Cochrane library. N 2,
[26.]
G. Sutherland.
Current approaches to the management of smoking cessation.
Drug, 62 (2002), pp. 53-61
[27.]
T. Lancaster, L.F. Stead.
Self-help interventions for smoking cessation. Cochrane Library. N 2,
[28.]
T. Lancaster, L.F. Stead.
Self-help interventions for smoking cessation. Cochrane Library. N 1,
[29.]
E. Park, J.K. Schultz, F. Tudiver, T. Campbell, L. Becker.
Enhancing partner support to improve smoking cessation. Cochrane Library. N 1,
[30.]
M.H. Ussher, R. West, A.H. Taylor, A. McEwen.
Exercise interventions for smoking cessation. Cochrane Library. N 3,
[31.]
C.A. Jiménez Ruiz.
Terapia sustitutiva con nicotina: aspectos prácticos.
Rev Clin Esp, 198 (1998), pp. 181-185
[32.]
P. Paoletti, E. Formai, F. Maggiorelli, R. Puntoni, G. Viegi, L. Carruzzi, et al.
Importance of baseline cotinine plasma values in smoking cessation: results from a double blind study with nicotine patch.
Eur Resp J, 9 (1996), pp. 643-651
[33.]
C. Silagy, D. Mant, G. Fowler, T. Lancaster.
Nicotine replacement therapy for smoking cessation. Cochrane Library. N 2,
[34.]
C. Silagy, T. Lancaster, L. Stead, D. Mant, G. Fowler.
Nicotine replacement therapy for smoking cessation. Cochrane Library. N 3,
[35.]
A.N. Thorndike, L. Biener, N.A. Rigotti.
Effect on smoking cessation of switching nicotine replacement therapy to over the counter status.
Am J Public Health, 92 (2002), pp. 437-442
[36.]
A. McNeill, J. Foulds, C. Bates.
Regulation of nicotine replacement therapy: a critique of current practice.
Addiction, 96 (2001), pp. 1757-1768
[37.]
C.A. Jiménez Ruiz, A. Ramos Pinedo, S. Flórez Martín, B. Steen, L. Ramos Casado.
Terapia sustitutiva con nicotina.
Manual de prevención y tratamiento del tabaquismo, pp. 93-109
[38.]
Consejo general de colegios oficiales de farmacéuticos. Base de datos de medicamentos. Disponible en URL: www.Portalfarm.com/home.nsf
[39.]
P. Tonnessen, P. Paoletti, G. Gustavsson, M.A. Russell, R. Saracci, A. Gulsvik, et al.
Higher dosage nicotine patches increase one-year smoking cessation rates: results from the European CEASE-trial.
Eur Respir, 13 (1999), pp. 238-246
[40.]
M. Schneider.
Nicotine therapy in smoking cessation. Pharmacokinetic considerations.
Clin Pharmacokinetic, 23 (1992), pp. 169-172
[41.]
T. Blondal, M. Frazon, A. Westein.
A double blind randomized trial of nicotine nasal spray as an aid in smoking cessation.
Eur Resp J, 10 (1997), pp. 1585-1590
[42.]
C.A. Jiménez Ruiz.
Terapia sustitutiva con nicotina.
Nicotina y tabaquismo. Nuevas perspectivas, pp. 151-183
[43.]
M. Dautzenberg.
Multicentre controlled study with nicotine pills,
[44.]
D.J.K. Balfour.
The pharmacology underlying pharmacotherapy for tobacco dependence: a focus on bupropion.
Int J Clin Pract, 56 (2001), pp. 79-83
[45.]
M. Jarvis, S. Powell, H. Marsh.
A meta-analysis of clinical studies confirms the effectiveness of bupropion SR in smoking cessation.7th Annual Conference of the Society for Research of Nicotine and Tobacco. Seattle, Washington, (2001),
[46.]
J.A. Johnston, J. Fiedler-Kelly, E.D. Glover, D.E. Pickman.
Relationship between drug exposure and the efficacy and safety of bupropion SR for smoking cessation.
Nicotine Tob Res, 23 (2001), pp. 744-752
[47.]
Zyban. Sustained relased tablets: product information,
[48.]
D.P. Tashkin, R. Kanner, W. Bailey, S. Buist, P. Anderson, M.A. Nides, et al.
Smoking cessation in patients with COPD: a double-blind, placebo-controlled, randomised study.
Lancet, 357 (2001), pp. 1571-1575
[49.]
S. Tonstad.
Use of bupropion SR in specific patient populations for smoking cessation.
Drug, 62 (2002), pp. 37-43
[50.]
H. Aubin.
Tolerability and safety of bupropion SR in the management of smoking cessation.
Drug, 62 (2002), pp. 45-52
[51.]
A. Joseph, S. Norman, L. Ferry, A. Prochezke, E. Westman, B. Steel, et al.
The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease.
N Engl J Med, 335 (1996), pp. 1792-1798
[52.]
Working group for the study of transdermal nicotine in patients with coronary artery disease.
Nicotine replacement therapy for patients with coronary disease.
Arch Intern Med, 154 (1994), pp. 985-995
[53.]
F. Huhtasaari, K. Asplund, V. Lundberg, B. Stegmair, P.O. Wester.
Tobacco and myocardial infarction.
Is snuff less dangerous than cigarettes? Bmj, 305 (1992), pp. 1252-1256
[54.]
L.S. Covey, A.H. Glassman, F. Statner, A. Jonhston.
Effects of history of alcoholism or major depression on smoking cessation.
Am J Psychiatry, 150 (1993), pp. 1546-1547
[55.]
R.D. Hurt, L.C. Dale, K.P. Offord.
Nicotine patch therapy for smoking cessation in recovering alcoholics.
Addiction, 90 (1995), pp. 1541-1546
[56.]
K.D. Hayford, C.A. Patten, T.A. Rummans, L.S. Covey.
Efficacy of bupropion for smoking cessation in smokers with a former history of major depression or alcoholism.
Br J Psychiatry, 174 (1999), pp. 173-178
[57.]
A.H. Glassman, F. Stetner, B.T. Walsh, L.S. Covey.
Heavy smokers, smoking cessation and clonidine: results of a double-blind randomised trial.
Jama, 259 (1988), pp. 2863-2866
[58.]
S.S. Smith, D.E. Joremby, S.J. Leischow, L.C. Dale.
Targeting smokers at high risk for relapse: treating women and those with a history of depression,
[59.]
W. Bjornson, C. Rand, J.E. Connet, B. Bailey.
Gender differences in smoking cessation after 3 years in the Lung Health Study.
Am J Public Health, 85 (1995), pp. 223-230
[60.]
G.E. Swan, L.M. Jack, G.M. Ward, D.W. Wetter.
Subgroup of smokers with different success rate after use of transdermal nicotine.
Addiction, 92 (1997), pp. 207-217
[61.]
D.E. Joremby, S.J. Leischow, M.A. Nides, A. Johnston, A. Glover.
A controlled trial of bupropion SR, a nicotine patch or both for smoking cessation.
N Engl J Med, 340 (1999), pp. 685-691
[62.]
A.W. Meyers, R.C. Klesges, S.E. Winders, G.R. Routh.
Are weight predictive of smoking cessation?: a prospective analysis.
J Consult Clin Psychol, 65 (1997), pp. 448-452
[63.]
N.A. Rigotti, A.N. Torndike, R. Niaura, G.F. Scharf, D.W. Wetter.
Post-cessation weight gain in smokers taking bupropion: the effect of gender,
[64.]
P. Tonnesen, J. Norregaard, U. Sawe, G. Gustavsson, E. Kruise.
Recycling with nicotine patches in smoking cessation.
Addiction, 88 (1993), pp. 533-539
[65.]
J.R. Hughes, J.A. Grass, J.L. Pilitteri.
Treatment resistant smokers. A pilot study of nicotine nasal spray and inhaler.
J Addict Dis, 19 (2000), pp. 95-100
[66.]
D.H. Gonzales, M.A. Nides, L.H. Ferry, A. Jonhston, J. Durcan.
Retreating relapse: bupropion SR v. placebo in adult cigarettes smokers previously treated with bupropion SR,
[67.]
D. Hatsukami, S. Rennard, R. Malcolm, D.H. Gonzales, M.A. Nides.
A multi-center study examining the effects of bupropion SR vs placebo as an aid to smoking reduction leading to cessation among smokers unwilling and unable to quit,
[68.]
T.F. Heatherton, L.T. Kozlowsky, R.C. Frecker, T. Baker, W. Whisler, K.O. Fagerström.
The Fagerström test for nicotine dependence: a revision of the Fagerström tolerance questionnaire.
Br J Addict, 86 (1991), pp. 1119-1127
[69.]
T.J. Payne, P.D. Smith, L.E. McCracken, W. McSherry, M.M. Antony.
Assessing nicotine dependence: a comparison of the FTQ with the FTND in a clinical sample.
Addict Behav, 19 (1994), pp. 307-317
[70.]
S. Shiffman, J.L. Pilliteri, S.L. Burton, J.M. Rohay, J.E. Gitchell.
Smokers beliefs about light and ultra light cigarettes.
Tob Control, 10 (2001), pp. 17-23
[71.]
J. Hughes, S. Higgins, et al.
Hatsukami. Effects of abstinence from tobacco, a critical review.
Research advances in alcohol and drug problems, pp. 317-398
[72.]
M.J. Durcan, G. Deener, J. White, A. Jonhston, D. Gonzales, R. Niaura, et al.
The effect of bupropion SR on cigarette craving after smoking cessation.
Clin Ther, 24 (2002), pp. 540-551
[73.]
A. Lindblan, K. Marsal, K. Andersson.
Effect of nicotine in human fetal flow.
Obstet Gynecol, 72 (1988), pp. 371-382
[74.]
C. Onkem.
Nicotine replacement during pregnancy.
Am J Health Behav, 20 (1996), pp. 300-303
[75.]
K. Wisborg, T. Brink, L. Birk, N. Jorgen.
Nicotine patches for pregnant smokers: a randomised controlled study.
Obstet Gynecol, 96 (2000), pp. 967-971
[76.]
K. Wisborg, T.B. Henriksen, M. Hedegaard, N.G. Secher.
Smoking cessation among pregnant women.
Ugeskr Laeger, 158 (1996), pp. 3784-3788
[77.]
P.R. Murray, W. Bailey, K. Daniels, W.M. Bjoruson, R. Kurnov, J. Connett, et al.
Safety of nicotine policrilex gum used by 3094 participants in the lung health study.
Chest, 109 (1996), pp. 438-445
[78.]
A. Joseph, S. Norman, L. Ferry, A. Prochezke, E. Westman, B. Steel, et al.
The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease. N.
Engl J Med, 335 (1996), pp. 1792-1798
[79.]
S. Tonstad, M. Murphy, C. Ashbury, T.H. Swan, H.T. Pietti, L.S. Covey, et al.
Effectiveness and tolerability of bupropion SR in smokers cardiovascular disease. Week 26 follow up phase results,
[80.]
J.I. Granda Orive, J.M. Martínez Albiach, T. Gutiérrez Jiménez, S. Flórez Martín, S. Solano Reina, C.A. Jiménez Ruiz.
Terapia sustitutiva con nicotina a altas dosis.
Prev Tab, 4 (2002), pp. 136-141
[81.]
M. Barrueco.
Algunos aspectos de la terapia sustitutiva con nicotina (TSN) que podrían presentar dificultades para el clínico a partir de la información contenida en las fichas técnicas.
Arch Bronconeumol, 37 (2001), pp. 219-220
[82.]
C.A. Jiménez Ruiz, M. Kunze, K.O. Fagerström.
Nicotine replacement: a new approach to reducing tobacco-related harm.
Eur Resp J, 11 (1998), pp. 473-479
[83.]
C.T. Bolliger, J.P. Zellweger, T. Danielsson, X. Biljon, A. Robidou, A. Westin, et al.
Smoking reduction with oral nicotine inhaler: double blind, randomised clinical trial of efficacy and safety.
Bmj, 321 (2000), pp. 329-333
[84.]
C.A. Jiménez Ruiz, S. Solano Reina, S. Alonso Viteri, M. Barrueco Ferrero, M. Torrecilla García, M. Hernández Mezquita.
Harm reduction. A treatment approach for resistant smokers with tobacco related symptoms.
Respiration, 69 (2002), pp. 452-455
[85.]
K.O. Haustein, J. Krause, H. Haustein.
How soon can biomarkers of hemorheology and cardiovascular harm detect smoking cessation or reduction,
Copyright © 2003. Sociedad Española de Neumología y Cirugía Torácica
